Atlas Trials

Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Clinical trial NCT05789589 · SUSPENDED

Trial details

NCT number
NCT05789589
Sponsor
Baptist Health South Florida
Status
SUSPENDED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CancerMetastasisMetastatic CancerBrain MetastasesBrain Metastases, Adult
Start date
2023-11-17
Primary completion
2027-03-16
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.